CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Worst, Thomas S., Weis, Cleo-Aron, Stöhr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M. and Erben, Philipp (2018) CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports 8 (1).Date of publication of this fulltext: 28 Jul 2021 17:01
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Scientific Reports | ||||
| Publisher: | Nature | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 8 | ||||
| Number of Issue or Book Chapter: | 1 | ||||
| Date | 2018 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | COMPREHENSIVE MOLECULAR CHARACTERIZATION; FREQUENT GENETIC ALTERATIONS; UROTHELIAL CARCINOMA; P16 EXPRESSION; FGFR3; P53; PAZOPANIB; SUBTYPES; CLASSIFICATION; IDENTIFICATION; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 46763 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric